Michael Keppler

Michael Keppler

Auto-generated profile, based on publicly available information

Michael Keppler

Institute of Pharmaceutical Sciences University of Freiburg Albertstr. 25 79104 Freiburg Germany

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2022 in Beilstein Journal of Organic Chemistry
Verified
Journal Article
Open access
PDF file
MKMichael Keppler
Michael Keppler
SMSandra Moser
Sandra Moser
HJHenning Jessen
Henning Jessen
CHChristoph Held
Christoph Held
JAJennifer N. Andexer
Jennifer N. Andexer
Polyphosphate kinases (PPKs) have become popular biocatalysts for nucleotide 5'-triphosphate (NTP) synthesis and regeneration. Two unrelated families are described: PPK1 and PPK2. They are structurally unrelated and use different catalytic mechanisms. PPK1 enzymes prefer the usage of adenosine 5'-triphosphate (ATP) for polyphosphate (polyP) synthesis while PPK2 enzymes favour the reverse reaction. With the emerging use of PPK enzymes in biosynthesis, a deeper understanding of the enzymes and their thermodynamic reaction course is of need, especially in comparison to other kinases. Here, we tested four PPKs from different organisms under the same conditions without any coupling reactions. In comparison to other kinases using phosphate donors with comparably higher phosphate transfer potentials that are characterised by reaction yields close to full conversion, the PPK-catalysed reaction reaches an equilibrium in which about 30% ADP is left. These results were obtained for PPK1 and PPK2 enzymes, and are supported by theoretical data on the basic reaction. At high concentrations of substrate, the different kinetic preferences of PPK1 and PPK2 can be observed. The implications of these results for the application of PPKs in chemical synthesis and as enzymes for ATP regeneration systems are discussed.

26 June 2023 in The FEBS Journal
Verified
Journal Article
Open access
PBPatricia Benčić
Patricia Benčić
MKMichael Keppler
Michael Keppler
MKMarco Kuge
Marco Kuge
DQDanye Qiu
Danye Qiu
LSLena M. Schütte
Lena M. Schütte
Christoph LoenarzChristoph Loenarz
Christoph Loenarz
Recent advances in mRNA therapeutics demand efficient toolkits for the incorporation of nucleoside analogues into mRNA suitable for downstream applications. Herein, we report the application of a versatile enzyme cascade for the triphosphorylation of a broad range of nucleoside analogues, including unprotected nucleobases containing chemically labile moieties. Our biomimetic system was suitable for the preparation of nucleoside triphosphates containing adenosine, cytidine, guanosine, uridine and non‐canonical core structures, as determined by capillary electrophoresis coupled to mass spectrometry. This enabled us to establish an efficient workflow for transcribing and purifying functional mRNA containing these nucleoside analogues, combined with mass spectrometric verification of analogue incorporation. Our combined methodology allows for analyses of how incorporation of nucleoside analogues that are commercially unavailable as triphosphates affect mRNA properties: The translational fidelity of the produced mRNA was demonstrated in analyses of how incorporated adenosine analogues impact translational recoding. For the SARS‐CoV‐2 frameshifting site, analyses of the mRNA pseudoknot structure using circular dichroism spectroscopy allowed insight into how the pharmacologically active 7‐deazaadenosine destabilises RNA secondary structure, consistent with observed changes in recoding efficiency.

4 February 2025 in ChemBioChem
Verified
Journal Article
Open access
MKMarco Kuge
Marco Kuge
MKMichael Keppler
Michael Keppler
FFFlorian Friedrich
Florian Friedrich
RSRaspudin Saleem‐Batcha
Raspudin Saleem‐Batcha
JWJuliana Winter
Juliana Winter
JAJennifer N. Andexer
Jennifer N. Andexer
Polyphosphate kinases (PPK) play crucial roles in various biological processes, including energy storage and stress responses, through their interaction with inorganic polyphosphate (polyP) and the intracellular nucleotide pool. Members of the PPK family 2 (PPK2s) catalyse polyP–consuming phosphorylation of nucleotides. In this study, we characterised two PPK2 enzymes from Bacillus cereus ( Bc PPK2) and Lysinibacillus fusiformis ( Lf PPK2) to investigate their substrate specificity and potential for selective nucleotide synthesis. Both enzymes exhibited a broad substrate scope, selectively converting over 85 % of pyrimidine nucleoside monophosphates (NMPs) to nucleoside diphosphates (NDPs), while nucleoside triphosphate (NTP) formation was observed only with purine NMPs. Preparative enzymatic synthesis of cytidine diphosphate (CDP) was applied to achieve an yield of 49 %. Finally, structural analysis of five crystal structures of Bc PPK2 and Lf PPK2 provided insights into their active sites and substrate interactions. This study highlights PPK2‐II enzymes as promising biocatalysts for the efficient and selective synthesis of pyrimidine NDPs.